Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J T Verweij

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Prenatal Diagnosis|September 11, 2024
Maternal Complications After Laser Surgery for Twin-to-Twin Transfusion Syndrome, a Cohort StudyM Gijtenbeek, F M M Prein, E J T Verweij, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 22, 2023
Dutch professionals' discussion preferences with the parents of extremely premature infants varied, but the trend was towards shared decision-makingR Geurtzen, L De Proost, A A E Verhagen, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|October 29, 2025
From concept to practice: Screening for fetal and neonatal alloimmune thrombocytopenia (FNAIT)R Pothof, T W de Vos, E Lopriore, et al.
American Journal of Obstetrics & Gynecology MFM|February 20, 2021
Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?Isabelle M C Ree, Renske M van 't Oever, Carolien Zwiers, et al.
Frontiers in Pediatrics|February 18, 2021
The Edge of Perinatal Viability: Understanding the Dutch PositionL De Proost, E J T Verweij, H Ismaili M'hamdi, et al.
Prenatal Diagnosis|May 12, 2023
Perinatal outcome after selective fetal reduction in monochorionic twin pregnancies: A comparison of techniques over a 20-year periodM J C van Hoek, J M M van Klink, E J T Verweij, et al.
Vox Sanguinis|March 17, 2021
Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcomeIsabelle M C Ree, Carolin F J Besuden, Vivianne E H J Wintjens, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|October 29, 2025
Long-term neurodevelopmental outcomes after intrauterine transfusion for alloimmune hemolytic disease of the fetus and newbornJeanine M M van Klink, Derek P de Winter, Renske M van 't Oever, et al.
The Lancet. Haematology|November 29, 2023
Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trialIsabelle M C Ree, Masja de Haas, Nan van Geloven, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 27, 2025
Comparison of intrauterine transfusion techniques in hemolytic disease of the fetus and newbornR M van 't Oever, V M van Duijn, F Slaghekke, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Prenatal Diagnosis|September 11, 2024
Maternal Complications After Laser Surgery for Twin-to-Twin Transfusion Syndrome, a Cohort StudyM Gijtenbeek, F M M Prein, E J T Verweij, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 22, 2023
Dutch professionals' discussion preferences with the parents of extremely premature infants varied, but the trend was towards shared decision-makingR Geurtzen, L De Proost, A A E Verhagen, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|October 29, 2025
From concept to practice: Screening for fetal and neonatal alloimmune thrombocytopenia (FNAIT)R Pothof, T W de Vos, E Lopriore, et al.
American Journal of Obstetrics & Gynecology MFM|February 20, 2021
Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?Isabelle M C Ree, Renske M van 't Oever, Carolien Zwiers, et al.
Frontiers in Pediatrics|February 18, 2021
The Edge of Perinatal Viability: Understanding the Dutch PositionL De Proost, E J T Verweij, H Ismaili M'hamdi, et al.
Prenatal Diagnosis|May 12, 2023
Perinatal outcome after selective fetal reduction in monochorionic twin pregnancies: A comparison of techniques over a 20-year periodM J C van Hoek, J M M van Klink, E J T Verweij, et al.
Vox Sanguinis|March 17, 2021
Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcomeIsabelle M C Ree, Carolin F J Besuden, Vivianne E H J Wintjens, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|October 29, 2025
Long-term neurodevelopmental outcomes after intrauterine transfusion for alloimmune hemolytic disease of the fetus and newbornJeanine M M van Klink, Derek P de Winter, Renske M van 't Oever, et al.
The Lancet. Haematology|November 29, 2023
Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trialIsabelle M C Ree, Masja de Haas, Nan van Geloven, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 27, 2025
Comparison of intrauterine transfusion techniques in hemolytic disease of the fetus and newbornR M van 't Oever, V M van Duijn, F Slaghekke, et al.
Pageof 3